Barclays lowered the firm’s price target on CDW (CDW) to $176 from $205 and keeps an Equal Weight rating on the shares post the Q2 report. The firm says the company’s Healthcare and Commercial units offset weakness in Education.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDW: